These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34112676)

  • 1. Alzheimer's drug approved despite murky results.
    Servick K
    Science; 2021 Jun; 372(6547):1141. PubMed ID: 34112676
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrine: first drug approved for Alzheimer's disease.
    Crismon ML
    Ann Pharmacother; 1994 Jun; 28(6):744-51. PubMed ID: 7919566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fewer blue lakes and more murky lakes across the continental U.S.: Implications for planktonic food webs.
    Leech DM; Pollard AI; Labou SG; Hampton SE
    Limnol Oceanogr; 2018 Nov; 63(6):2661-2680. PubMed ID: 31942083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E4 serum concentration for increased sensitivity and specificity of diagnosis of drug treated Alzheimer's disease patients vs. drug treated parkinson's disease patients vs. age-matched normal controls.
    Goldknopf IL; Park HR; Sabbagh M
    Curr Alzheimer Res; 2012 Dec; 9(10):1149-67. PubMed ID: 22950864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
    Sonkusare SK; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating Alzheimer's disease by targeting iron.
    Nikseresht S; Bush AI; Ayton S
    Br J Pharmacol; 2019 Sep; 176(18):3622-3635. PubMed ID: 30632143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of anti-Alzheimer's disease drug based on beta-amyloid hypothesis].
    Sugimoto H
    Yakugaku Zasshi; 2010 Apr; 130(4):521-6. PubMed ID: 20371996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits and risks of add-on therapies for Alzheimer's disease.
    Magierski R; Sobow T
    Neurodegener Dis Manag; 2015 Oct; 5(5):445-62. PubMed ID: 26517312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study.
    Desai RJ; Varma VR; Gerhard T; Segal J; Mahesri M; Chin K; Nonnenmacher E; Gabbeta A; Mammen AM; Varma S; Horton DB; Kim SC; Schneeweiss S; Thambisetty M
    Alzheimers Dement (N Y); 2020; 6(1):e12095. PubMed ID: 33304987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives.
    de Castro AA; da Cunha EFF; Pereira AF; Soares FV; Leal DHS; Kuca K; Ramalho TC
    Curr Alzheimer Res; 2018; 15(12):1161-1178. PubMed ID: 30101709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
    Hashimoto M; Kazui H; Matsumoto K; Nakano Y; Yasuda M; Mori E
    Am J Psychiatry; 2005 Apr; 162(4):676-82. PubMed ID: 15800138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationalizing therapeutic approaches in Alzheimer's disease.
    Grossberg GT
    CNS Spectr; 2005 Nov; 10(11 Suppl 18):17-21. PubMed ID: 16273026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.
    Akhondzadeh S; Noroozian M; Mohammadi M; Ohadinia S; Jamshidi AH; Khani M
    J Clin Pharm Ther; 2003 Feb; 28(1):53-9. PubMed ID: 12605619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer's Disease.
    Arastoo M; Lofthouse R; Penny LK; Harrington CR; Porter A; Wischik CM; Palliyil S
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33212983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly.
    VanDenBerg CM; Kazmi Y; Jann MW
    Drugs Aging; 2000 Feb; 16(2):123-38. PubMed ID: 10755328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria in Alzheimer's Disease and Diabetes-Associated Neurodegeneration: License to Heal!
    Cardoso SM; Correia SC; Carvalho C; Moreira PI
    Handb Exp Pharmacol; 2017; 240():281-308. PubMed ID: 28251365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.